Disclosure Of First-Time Adoption [Text Block]

ROQUEFORT THERAPEUTICS PLC - Filing #5968009

Concept	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	As at 2024-12-31	As at 2024-12-31	2024-01-01 to 2024-12-31	As at 2024-12-31	As at 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	As at 2024-12-31	As at 2024-12-31	As at 2024-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31
Disclosure of first-time adoption [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of comparative information prepared under previous GAAP [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Equity	—	—	5,265,071 GBP	4,619,793 GBP	—	1,357,366 GBP	69,931 GBP	—	—	—	—	3,700,000 GBP	407,000 GBP	4,889,019 GBP	—	5,499,543 GBP	4,293,268 GBP	—	—	—	4,403,094 GBP	—	1,291,500 GBP	12,680 GBP	—	3,700,000 GBP	—	385,537 GBP	7,206,636 GBP	375,135 GBP	2,548,728 GBP	4,403,094 GBP	14,365 GBP	3,700,000 GBP	1,291,500 GBP
Comprehensive income	– GBP	– GBP	—	—	57,251 GBP	—	—	971,803 GBP	914,552 GBP	– GBP	– GBP	—	—	—	1,717,495 GBP	—	—	1,744,540 GBP	– GBP	27,045 GBP	—	– GBP	—	—	– GBP	—	– GBP	—	—	—	—	—	—	—	—
Profit (loss)	– GBP	– GBP	—	—	– GBP	—	—	971,803 GBP	971,803 GBP	– GBP	– GBP	—	—	—	1,744,540 GBP	—	—	1,744,540 GBP	– GBP	– GBP	—	– GBP	—	—	– GBP	—	– GBP	—	—	—	—	—	—	—	—